SimplyCash

Is the correction over?

Long
NASDAQ:BEAM   Beam Therapeutics Inc
We have been seeing a brutal selloff/shorting since mid-February of this year - especially within the genomics sectors, a darling sector for ARKK investments. This is one of their highest conviction names. The chart is indicating a possible near-term bottom per the formation of a long-term trendline and sentiment slowly shifting with more buying volume this week.